Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 1
520
Views
9
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue

, , , , &
Pages 106-119 | Received 28 Nov 2017, Accepted 28 Dec 2017, Published online: 31 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kaoru Kobayshi, Yoshikazu Abe, Asuka Kawai, Takao Furihata, Hiroshi Harada, Takuro Endo & Hiroo Takeda. (2019) Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro. Xenobiotica 49:12, pages 1434-1446.
Read now

Articles from other publishers (8)

Tomoyuki Ijiro, Atsushi Yaguchi, Ayaka Yokoyama & Sumiyoshi Kiguchi. (2022) Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside‐induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission. Clinical and Experimental Pharmacology and Physiology 49:9, pages 950-958.
Crossref
Marieke Hyke Algera, Joseph F. Cotten, Monique van Velzen, Marieke Niesters, Martijn Boon, Daniel S. Shoham, Kaye E. Dandrea, Rutger van der Schrier & Albert Dahan. (2022) Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?. Pharmacology Research & Perspectives 10:3.
Crossref
Kah Hui Yap, Shahrul Azmin, Jemaima Che Hamzah, Norfazilah Ahmad, Bart van de Warrenburg & Norlinah Mohamed Ibrahim. (2021) Pharmacological and non-pharmacological management of spinocerebellar ataxia: A systematic review. Journal of Neurology 269:5, pages 2315-2337.
Crossref
Kaoru Kobayashi, Yoshikazu Abe, Asuka Kawai, Takao Furihata, Takuro Endo & Hiroo Takeda. (2020) Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P‐Glycoprotein Inhibitor (Itraconazole). The Journal of Clinical Pharmacology 60:10, pages 1314-1323.
Crossref
Tomoyuki Ijiro, Atsushi Yaguchi, Ayaka Yokoyama, Yoshikazu Abe & Sumiyoshi Kiguchi. (2020) Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya. European Journal of Pharmacology 882, pages 173271.
Crossref
Jean-Louis Charli, Adair Rodríguez-Rodríguez, Karina Hernández-Ortega, Antonieta Cote-Vélez, Rosa María Uribe, Lorraine Jaimes-Hoy & Patricia Joseph-Bravo. (2020) The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?. Frontiers in Pharmacology 11.
Crossref
Masatoyo Nishizawa, Osamu Onodera, Akihiro Hirakawa, Yoshitaka Shimizu & Masayuki Yamada. (2020) Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. Journal of Neurology, Neurosurgery & Psychiatry 91:3, pages 254-262.
Crossref
Naotake Kobayashi, Norihito Sato, Katsuji Sugita, Kouji Takahashi, Tamio Sugawara, Yukio Tada & Takayoshi Yoshikawa. (2019) Synthesis and evaluation of in vivo anti‐hypothermic effect of all stereoisomers of the thyrotropin‐releasing hormone mimetic: Rovatirelin Hydrate. Journal of Peptide Science 25:12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.